Jade Biosciences (JBIO) Change in Cash (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Change in Cash data on file, last reported at -$33.4 million in Q1 2026.

• Quarterly Change in Cash fell 71.42% year-over-year to -$33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 96.26% YoY) and the FY2025 annual result came in at $19.1 million, up 85.69% from the prior year.
• Change in Cash retreated to -$33.4 million in Q1 2026, from $38.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $171.0 million in Q2 2025 to a low of -$170.8 million in Q3 2025.
• A 5-year average of $6.1 million and a median of -$2.9 million in 2022 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 5148.53% in 2023, down 39395.45% in 2023.
• Tracing JBIO's Change in Cash over 5 years: stood at -$22000.0 in 2022, then plunged by 39395.45% to -$8.7 million in 2023, then jumped by 898.55% to $69.4 million in 2024, then sank by 44.76% to $38.3 million in 2025, then slumped by 187.01% to -$33.4 million in 2026.
• The last three Change in Cash figures came in at -$33.4 million (Q1 2026), $38.3 million (Q4 2025), and -$170.8 million (Q3 2025), per Business Quant data.